This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Remedies for standard-essential patents addressed in policy statement by US DOJ, Patent Office, Standards Institute

( December 19, 2019, 20:45 GMT | Official Statement) -- MLex Summary: The US Department of Justice, the Patent and Trademark Office, and the National Institute of Standards and Technology issued a joint policy statement regarding the treatment of standard-essential patents where the patent holder has agreed to license its patents on fair, reasonable, and non-discriminatory terms. The statement clarifies that a patent owner’s promise to license a patent on Frand terms isn't a bar to obtaining any particular remedy, including injunctive relief.See attached joint policy statement. Text of press release follows in full. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections